Search
Descriptor English: mRNA Vaccines
Descriptor Spanish: Vacunas de ARNm
Descriptor vacunas de ARNm
Entry term(s) vacuna de ARN
vacuna de ARN autoamplificado
vacuna de ARN mensajero
vacuna de ARN transamplificado
vacuna de ARNaa
vacuna de ARNm
vacuna de ARNta
vacuna de RNA
vacuna de mRNA
vacuna de saRNA
vacuna de taRNA
vacunas de ARN
vacunas de ARN desnudo
vacunas de ARN mensajero
vacunas de mRNA
Scope note: Vacunas formuladas con ARNm recombinantes que se obtienen de células huésped que traducen el ARNm y presentan las proteínas traducidas al sistema inmunitario como antígenos de forma similar a como ocurriría durante una infección natural. Esto induce respuestas inmunitarias humorales y celulares frente al antígeno codificado.
Descriptor Portuguese: Vacinas de mRNA
Descriptor French: Vaccins à ARNm
Entry term(s): Messenger RNA Vaccines
Naked RNA Vaccines
RNA Vaccine
RNA Vaccine, Self-Amplifying
RNA Vaccines
Self Amplifying RNA Vaccine
Self-Amplifying RNA Vaccine
Trans Amplifying RNA Vaccine
Vaccine, RNA
Vaccine, Self-Amplifying RNA
Vaccine, saRNA
Vaccine, taRNA
Vaccines, RNA
mRNA Vaccine
saRNA Vaccine
taRNA Vaccine
Tree number(s): D12.776.828.868.228.500
D20.215.894.860.900.450
D20.215.894.865.450.500
D23.050.865.450.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000087503
Scope note: Vaccines formulated with recombinant mRNAs which are taken up by the host cells that translate the mRNA and present the translated proteins to the immune system as antigens in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigen.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Vaccines, DNA (2001-2021)
Public MeSH Note: 2022
History Note: 2022
DeCS ID: 59637
Unique ID: D000087503
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2022/01/01
Date of Entry: 2021/07/09
Revision Date: 2023/05/16
mRNA Vaccines - Preferred
Concept UI M000738307
Scope note Vaccines formulated with recombinant mRNAs which are taken up by the host cells that translate the mRNA and present the translated proteins to the immune system as antigens in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigen.
Preferred term mRNA Vaccines
Entry term(s) Messenger RNA Vaccines
mRNA Vaccine
RNA Vaccines - Broader
Concept UI M000762294
Preferred term RNA Vaccines
Entry term(s) Naked RNA Vaccines
RNA Vaccine
Vaccine, RNA
Vaccines, RNA
Self-Amplifying RNA Vaccine - Narrower
Concept UI M000762590
Preferred term Self-Amplifying RNA Vaccine
Entry term(s) RNA Vaccine, Self-Amplifying
Self Amplifying RNA Vaccine
Vaccine, Self-Amplifying RNA
Vaccine, saRNA
saRNA Vaccine
Trans Amplifying RNA Vaccine - Narrower
Concept UI M000762591
Preferred term Trans Amplifying RNA Vaccine
Entry term(s) Vaccine, taRNA
taRNA Vaccine



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey